- Accepted/In press
- PublishedBenjamin Fisher, 31 Jan 2020, In : Lancet Rheumatology.
Research output: Contribution to journal › Comment/debate
- E-pub ahead of print
Assessment of the anti-CD40 antibody iscalimab in patients with primary Sjögren's syndrome: a multicentre, randomised, double-blind, placebo-controlled, parallel group proof-of-concept studyBenjamin Fisher, Francesca Barone, Simon Bowman & 8 others, , 23 Jan 2020, In : Lancet Rheumatology.
Research output: Contribution to journal › Article